Covidien has announced availability of the EverFlex+(TM) Self-Expanding Peripheral Stent System in Europe.
Covidien
Covidien Redefines Surgical Stapling with New Tri-Staple Technology Platform
The new Endo GIA stapling system includes an ergonomically enhanced, lightweight handle designed for precise control. The easy-to-use stapling solution … continue reading “Covidien Redefines Surgical Stapling with New Tri-Staple Technology Platform”
Covidien Announces Plans for Respiratory Product Lines
Covidien today announced definitive agreements to sell its Sleep Diagnostics and Oxygen Therapy product lines and a proposal to sell its Sleep Therapy product line.
Covidien ForceTriad Energy Platform Now Compatible With da Vinci® Surgery
Covidien today announced that its ForceTriad energy platform is now compatible with the da Vinci, da Vinci® S, and da Vinci® Si Surgical Systems.
Covidien Features New Devices for Minimally Invasive Surgery and Soft Tissue Repair at ASMBS 2009
Covidien, a leading global provider of healthcare products, will showcase a number of its most recent innovations in minimally invasive surgery and soft tissue repair at the American Society for Metabolic & Bariatric Surgery annual meeting on June 21-26, 2009, in Grapevine, Texas.
Covidien Launches Alarm Management System For The Nellcor OxiMax N-600x Pulse Oximeter
Covidien, a leading global supplier of healthcare products, today announced the global launch of its Alarm Management System for the Nellcor OxiMax N-600x pulse oximeter.
Covidien Announces Definitive Agreement to Acquire VNUS Medical Technologies, Inc.
Covidien and VNUS Medical Technologies, Inc. today announced that Covidien has reached a definitive agreement to acquire VNUS, a developer of medical devices for minimally invasive treatment of venous reflux disease.
Covidien Receives FDA Clearance For New Pulse Oximeter With OxiMax SPD™ Alert
Covidien announced today that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert.
Covidien Receives FDA Clearance for the Nellcor™ OxiMax™ N-600x™ Pulse Oximeter with OxiMax SPD™ Alert
Covidien, a leading global provider of healthcare products, today announced that the United States Food and Drug Administration has issued a 510(k)marketing clearance for the Nellcor™ OxiMax™ N-600x™ pulse oximeter with OxiMax SPD™ alert for adults.
Covidien Reports First-Quarter 2009 Results
Covidien Ltd. today reported results for the first quarter of fiscal 2009 (October – December 2008). First-quarter net sales rose 6% to $2.5 billion from $2.3 billion a year ago, fueled by very strong growth in Pharmaceutical Products and continued strength in Medical Devices and Medical Supplies.
Covidien Introduces the SprayShield Adhesion Barrier System to the European Marketplace
Sprayable hydrogel technology in treatment of post-surgical adhesions
Covidien Launches Parietex ProGrip Hernia Repair Mesh
First and Only Self-Gripping, Easy-To-Use Repair System for Inguinal Hernias
Covidien Launches Evident Microwave Ablation System
Covidien Launches Evident Microwave Ablation System Offering Surgical Oncologists and Interventional Radiologists Fast, Efficient Tool to Ablate Soft Tissue